More About The Prasad Adusumilli Lab Minus iconIcon indicating subtraction, or that the element can be closed. Plus IconIcon indicating addition, or that the element can be opened. Arrow (down) icon.An arrow icon, usually indicating that the containing element can be opened and closed.

Marissa Mayor

Research Scholar

Start Year

2014

End Year

2016

Awards and Scholarships

NIH T-32 Research Fellowship

Current Employment

Surgical Resident, Beth Israel Medical Center, New York, NY

Publications

Manuscripts

Abstracts/Presentations

  • Zeltsman M, Villena-Vargas J, Rimner A, Mayor M, Jones DR, Adusumilli PS. Tumor-targeted radiation promotes abscopal efficacy of regionally administered CAR T cells: A rationale for clinical trial. International Association for the Study of Lung Cancer (IASLC) 17th World Conference on Lung Cancer. December 4-7, 2016; Vienna, Austria.
  • Morello A, Villena-Vargas J, Mayor M, Bograd AJ, Jones DR, Sadelain M,  Adusumilli PS. Mesothelin-Targeted CAR T-Cell Therapy for the Treatment of Heterogeneous Antigen-Expressing Lung Adenocarcinoma. International Association for the Study of Lung Cancer (IASLC) 16th World Conference on Lung Cancer. September 6-9, 2015; Denver, CO.
  • Mayor M, Villena-Vargas J, de Biasi A, Morello A, Jones DR, Sadelain M, Adusumilli PS. Tumor-Targeted Radiation Therapy Helps Overcome the Solid Tumor T-Cell Infiltration Barrier and Promotes Mesothelin CAR T-Cell Therapy. International Association for the Study of Lung Cancer (IASLC) 16th World Conference on Lung Cancer. September 6-9, 2015; Denver, CO.
  • Cherkassky L, Morello A, Villena-Vargas J, Mayor M, Jones DR, Sadelain M, Adusumilli PS. Genetic-Engineering Strategies to Enhance CAR T-Cell Therapy Efficacy against PD-L1 Expressing Lung Adenocarcinoma and Mesothelioma. International Association for the Study of Lung Cancer (IASLC) 16th World Conference on Lung Cancer. September 6-9, 2015; Denver, CO.
  • Ujiie H, Eguchi T, Mayor M, Kadota K, Travis WD, Jones DR, Sadelain M, Adusumilli PS. Targetable Cancer-Associated Antigens for Immunotherapy in Malignant Pleural Mesothelioma (MPM) - Mesothelin, CA125 and WT-1. International Association for the Study of Lung Cancer (IASLC) 16th World Conference on Lung Cancer. September 6-9, 2015; Denver, CO.